| Characteristic | All applications n = 4725 | Health services and policy applications n = 444 | ||||||
|---|---|---|---|---|---|---|---|---|
| No. of applications | % sustained | OR (95% CI) | No. of applications | % sustained | OR (95% CI) | |||
| Sex, age of PI, yr | ||||||||
| Female, < 45 (reference) | 633 | 32.9 | 1.00 | 80 | 31.3 | 1.00 | ||
| Female, > 45 | 578 | 36.2 | 1.21 (0.90-1.63) | 104 | 19.2 | 0.42 (0.18-1.01) | ||
| Male, < 45 | 1346 | 43.7 | 1.18 (0.93-1.50) | 88 | 22.7 | 0.65 (0.28-1.54) | ||
| Male, > 45 | 1611 | 48.0 | 1.45 (1.13-1.84) | 129 | 35.7 | 1.36 (0.62-3.00) | ||
| Missing age or sex | 557 | 31.8 | 1.00 (0.74-1.35) | 43 | 25.6 | 0.52 (0.18-1.48) | ||
| Characteristics of the first funded grant | ||||||||
| Institutional critical mass, applicants (HSR) | ||||||||
| < 50 (< 10) (reference) | 512 | 21.1 | 1.00 | 48 | 10.4 | 1.00 | ||
| 50-100 (10-20) | 178 | 21.9 | 1.32 (0.79-2.20) | 64 | 23.4 | 2.28 (0.62-8.35) | ||
| 101-250 (20-35) | 1000 | 43.1 | 1.85 (1.37-2.51) | 91 | 26.4 | 2.79 (0.83-9.35) | ||
| 251-350 (35-50) | 902 | 45.1 | 2.04 (1.50-2.79) | 105 | 35.2 | 3.83 (1.19-12.4) | ||
| > 350 (> 50) | 2133 | 45.5 | 2.03 (1.52-2.70) | 136 | 30.1 | 3.88 (1.21-12.5) | ||
| No. of co-investigators | ||||||||
| 1 (reference) | 2544 | 46.7 | 1.00. | 34 | 29.4 | 1.00 | ||
| 2 | 558 | 37.8 | 0.76 (0.61-0.96) | 28 | 25.0 | 1.36 (0.28-6.73) | ||
| 3 | 432 | 29.9 | 0.67 (0.50-0.88) | 51 | 11.8 | 0.59 (0.12-2.87) | ||
| 4 | 309 | 33.0 | 0.84 (0.61-1.16) | 59 | 23.7 | 1.08 (0.26-4.51) | ||
| ≥ 5 | 882 | 36.8 | 1.06 (0.82-1.36) | 272 | 31.3 | 1.22 (0.33-4.47) | ||
| Pillar | ||||||||
| Biomedical (reference) | 2698 | 52.8 | 1.00 | NA | ||||
| Clinical | 484 | 36.4 | 0.47 (0.36-0.62) | |||||
| Health services/policy | 334 | 24.0 | 0.34 (0.24-0.49) | |||||
| Pop and public health | 523 | 26.6 | 0.52 (0.39-0.71) | |||||
| Missing | 686 | 20.0 | 0.77 (0.58-1.02) | |||||
| Funding source | ||||||||
| Open competition (reference) | 2934 | 51.5 | 1.00 | 210 | 32.4 | 1.00 | ||
| Strategic competition | 1791 | 24.8 | 1.11 (0.92-1.34) | 234 | 23.1 | 1.36 (0.76-2.44) | ||
| Grant type | ||||||||
| New grant (reference) | 3615 | 33.7 | 1.00 | 430 | 26.5 | 1.00 | ||
| Renewal | 1110 | 66.6 | 3.01 (2.48-3.66) | 14 | 57.1 | 2.32 (0.39-13.9) | ||
| Duration of grant (per month) | 4725 | 41.8 (19.8) | 1.07 (1.06-1.08) | 444 | 37.7 (19.7) | 1.08 (1.06-1.10) | ||
| Characteristics during follow-up | ||||||||
| Funds applied for: follow-up | ||||||||
| Both open and strategic (reference) | 2644 | 48.9 | 1.00 | 289 | 36.3 | 1.00 | ||
| Open only | 893 | 42.9 | 0.75 (0.62-0.90) | 38 | 26.3 | 0.70 (0.34-2.04) | ||
| Strategic only | 506 | 27.1 | 0.56 (0.41-0.75) | 71 | 7.0 | 0.39 (0.13-1.19) | ||
| Had a CIHR salary award | ||||||||
| No (reference) | 3949 | 38.0 | 1.00 | 381 | 25.7 | 1.00 | ||
| Yes | 776 | 58.9 | 2.21 (1.81-2.69) | 63 | 38.1 | 1.30 (0.64-2.66) | ||
| Resubmission during follow-up | ||||||||
| No (reference) | 2269 | 40.3 | 1.00 | 207 | 14.5 | 1.00 | ||
| Yes | 2456 | 42.4 | 1.10 (0.94-1.29) | 237 | 38.8 | 3.79 (1.99-7.22) | ||
| Switched pillars | ||||||||
| No (reference) | 3583 | 41.4 | 1.00 | 177 | 16.4 | 1.00 | ||
| Yes | 1142 | 41.4 | 1.63 (1.34-1.98) | 267 | 34.8 | 2.20 (1.18-4.11) | ||
| Switched universities | ||||||||
| No (reference) | 3735 | 40.9 | 1.00 | 281 | 25.6 | 1.00 | ||
| Yes | 990 | 43.1 | 1.43 (1.18-1.74) | 163 | 30.7 | 1.11 (0.63-1.98) | ||
Note: CI = confidence interval, HSR = health services research, NA = not applicable, OR = odds ratio, PI = principal investigator.
*Model adjusted for amount requested.